Is Alcohol Good, Bad, or Neutral for Cardiovascular Health?

In the 2018 Guidelines on Hypertension, commandment no. 6 states that we should make lifestyle interventions such as sodium restriction, healthy eating, regular exercise, weight control, and smoking cessation, and also alcohol moderation.

¿El alcohol es bueno, malo o neutro para la salud cardiovascular?It is clear that heavy alcohol consumption induces hypertension and may probably be one of the main causes of secondary hypertension, but few sources detail what a moderate or “healthy” consumption is.

There are consistent observational data to indicate that there is an association between alcohol use and cardiovascular events, and that, as a whole, it is U-shaped. In other words, low or moderate alcohol consumption (up to one drink or 12.5 g alcohol per day in women and up to two drinks or 25 g per day in men) are associated with a reduced risk of overall cardiovascular events and mortality, compared with absolute abstinence or excessive consumption.


Read also: Progress of patients with hypertrophic cardiomyopathy treated with alcohol septal ablation.


The alcohol content of a beverage is expressed in degrees and it measures the content of absolute alcohol in 100 cm3, i.e. the alcohol percentage in a beverage. For example, if we have a 13-degree wine, that means that it contains 13 cm3 of absolute alcohol for every 100 cm3 of wine. In product labels, alcoholic content is expressed as (°) or vol%. The calculation would be as follows: consumed volume (in cm3) × alcohol content × 0.8, and then divide all by 100. We must ask the patient about the type of beverage (so as to get the alcohol content) and the amount consumed (so as to get the volume, in cm3) in order to calculate whether such consumption is good or bad for their health.

In any case, this generalization masks important aspects that merit closer examination.

Patterns of drinking, the type of alcohol consumed, and factors associated with alcohol consumption, such as socio-economic status and dietary patterns, may modify significantly such generalization. Well-established cardiac disease also implies differences, particularly for patients with left ventricular dysfunction.


Read also: Alcohol dilemma: Cardiovascular enjoyment and benefits versus cancer.


Furthermore, the effects of alcohol on coronary pathologies may differ from its effects on arrhythmias or heart failure risk, and they may also differ on ischaemic stroke and intracerebral haemorrhage.

It is important to consider that even if there is a modest cardiovascular benefit derived from moderate consumption, it may imply a risk of cancer and cirrhosis.

Finally, the data supporting this modest benefit have emerged from observational studies that are subject to many methodological limitations and potential confounding variables.


Read also: MitraClip in the “Real World”.


Consequently, for the time being, it may be better to advise restraint as opposed to support consumption to reduce cardiovascular risk.

leong2019-libre-para-publicar

Original title: Are the Cardiac Effects of Alcohol Good, Bad, or Neither?

Reference: Leong DP et al. Eur Heart J. 2019 Mar 1;40(9):712-714.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...